Long-term follow-up of genetically confirmed patients with familial hypercholesterolemia from the treatment with the first-generation statins to monoclonal anti-PCSK9 antibodies. (December 2020) - Pasta, A.; Cremonini, A.L.; Formisano, E.; Fresa, R.; Bertolini, S.; Pisciotta, L.